Owkin

Bronze Sponsor

Owkin is a French-American startup that uses artificial intelligence to find the right treatment for every patient. Our focus is to use AI to discover and develop better treatments for unmet medical needs, starting with the fight against cancer.

We use AI to identify new drug candidates, de-risk and accelerate clinical trials and build diagnostic tools that improve patient outcomes. 

Using federated learning, a pioneering collaborative AI framework, Owkin enables medical and biopharma partners to unlock valuable insights from siloed datasets, while protecting patient privacy and securing proprietary data. 

Owkin was co-founded by Thomas Clozel MD, a former assistant professor in clinical onco-hematology, and Gilles Wainrib, a pioneer in the field of machine learning in biology, in 2016.

Owkin has published research in Nature Medicine, Nature Communications and Hepatology, among other leading journals. We work with the most prominent cancer centers and biopharma companies in the world. Our data science team features several Kaggle Masters and DREAM Challenge top performers.

Owkin has raised over $255 million and became a unicorn in November 2021 through a $180 million investment from biopharma company Sanofi.

website